94 Maintenance of efficacy and safety with lebrikizumab up to one year of treatment in patients with moderate-to-severe atopic dermatitis with or without topical corticosteroids

Details

Language :

English

ISSN :

0022202X and 15231747

Volume :

143

Issue :

11, Number 11 Supplement 1

Database :

Supplemental Index

Journal :

Journal of Investigative Dermatology

Publication Type :

Periodical

Accession number :

ejs64426352

Full Text :

https://doi.org/10.1016/j.jid.2023.09.102